The current peptide craze and what the long-term impact could be for pharmacies
Nicolette Mathey, PharmD
Founder and CEO,
Atrium24
Anne West, PharmD
Clinical Pharmacist,
Atrium24
Michelle Barney, PharmD
Clinical Solutions Manager,
Lumistry
Where is the peptide market headed next—and how should pharmacies prepare?
Join us for an insightful conversation with Dr. Nicolette Mathey, PharmD, Founder and CEO of Atrium24, and Dr. Anne West, PharmD, Clinical Pharmacist at Atrium24, as we explore the growing demand for peptides among patients—and the opportunity this presents for pharmacies.
In this session, we'll cover:
Category 1 vs. Category 2 peptides and potential changes on the horizon
Sourcing strategies for 503A vs 503B (& best practices for vetting partners)
Leveraging telemedicine to compete with direct-to-consumer platforms
Marketing your pharmacy as a longevity destination to patients and prescribers
Don't miss this opportunity to learn how your pharmacy can embrace this market shift to better serve patients and create sustainable growth!